A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia
Clinical trial NCT06860269 · RECRUITING
Trial details
- NCT number
- NCT06860269
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-06
- Primary completion
- 2035-03-15
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.